KRAS and neoplasm: When stratified according to tissue biopsy sites, ctDNA was numerically more concordant with metastatic site tissue‐DNA than primary tumor DNA, although there were no statistical differences observed (78% vs 65% in TP53, 100% vs 74% in KRAS and 100% vs 87% in PIK3CA).